Rankings
▼
Calendar
NUVB Q1 2025 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena
NUVB
Nuvation Bio Inc.
$2B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
$990,000
32.1% margin
Operating Income
-$59M
-1913.2% margin
Net Income
-$53M
-1726.2% margin
EPS (Diluted)
$-0.16
QoQ Revenue Growth
-46.0%
Cash Flow
Operating Cash Flow
-$43M
Free Cash Flow
-$43M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$492M
Total Liabilities
$73M
Stockholders' Equity
$419M
Cash & Equivalents
$48M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$0
—
Gross Profit
$990,000
$0
—
Operating Income
-$59M
-$20M
-192.1%
Net Income
-$53M
-$15M
-259.9%
Revenue Segments
Product Revenue
$779,000
76%
Royalty Revenue
$249,000
24%
Geographic Segments
CHINA
$3M
94%
JAPAN
$200,000
6%
← FY 2025
All Quarters
Q2 2025 →